Ifu ya Tadalafil CAS 171596-29-5 Ubuziranenge bwa Tadalafil 99%
Ibisobanuro birambuye
Tadalafil ni ifu yera ya kirisiti ya kirisiti. Ntishobora gushonga mumazi, ikagaragaza gusa imbaraga nkeya, kandi ntigishobora gukemuka muri alcool.Ibintu byera ntabwo bihumura kandi ntabwo biryoshye, byerekana nkifu nziza, ya kristu.
Igikorwa cyibanze cya Tadalafil nukuvura imikorere mibi yumugabo wongera umuvuduko wamaraso mugitsina mugihe cyo gukangura imibonano mpuzabitsina. Ibyo bigerwaho muguhagarika enzyme fosifisiyose yubwoko bwa 5 (PDE5), ishinzwe kwangirika kwa cyclic guanosine monophosphate (cGMP) muri corpus cavernosum. cy'imboro.Mu kubuza PDE5, tadalafil ituma vasodilasiyo yamara igihe kinini kandi ikongera umuvuduko wamaraso, ifasha abagabo bafite imikorere mibi yumugabo kugera no gukomeza kwihagararaho. Bitandukanye nindi miti ya ED, tadalafil ifite igihe kirekire cyibikorwa, hamwe ningaruka akenshi ziramba. kugeza ku masaha 36, ukayita izina "ibinini bya weekend."
Tadalafil yerekanwa cyane cyane kuvura imikorere mibi (ED) kubagabo bakuze. Iraboneka muburyo bwa tablet kubuyobozi bwo munwa, mubipimo biri hagati ya mg 2,5 na mg 20, ukurikije ibyo umurwayi akeneye nuburyo arimo kuvurwa. Icyifuzo cyo gutangira abarwayi benshi ni mg 10, gifatwa mbere yimibonano mpuzabitsina iteganijwe, hamwe nibiryo cyangwa bidafite ibiryo. Igipimo gishobora guhindurwa hashingiwe ku kwihanganira no kugarura umuntu ku giti cye. Usibye kuba ikoreshwa mu gukora nabi, tadalafil yemerewe kandi kuvura ibimenyetso n'ibimenyetso bya hyperplasia benigne prostate (BPH), indwara irangwa na glande nini ya prostate. Iyo BPH iherekejwe no kudakora neza, tadalafil irashobora gutanga inyungu ebyiri mugukemura icyarimwe icyarimwe.
Byongeye kandi, tadalafil ikoreshwa mugucunga hypertension yimpyiko (PAH) kubagabo nabagore. Muri iyi porogaramu, ifasha kongera ubushobozi bwimyitozo ngororamubiri no gutinda kwangirika kwindwara.
Mu gusoza, tadalafil ni ifu yera ya kirisiti ya kirisiti ifite imbaraga nkeya, ikoreshwa cyane cyane mukuvura imikorere mibi yumugabo, hyperplasia nziza ya prostate, hamwe na hypertension yimpyiko. Nka PDE5 inhibitor, yorohereza umuvuduko wamaraso mubice bimwe byumubiri, cyane cyane imboro, ituma imikorere myiza yumugabo igenda neza. Byongeye kandi, igihe kirekire cyibikorwa cyacyo gitandukanya nindi miti yo mucyiciro cyayo, itanga ihinduka kandi ryihuse kubantu bashaka kwivuza ED.